Related Experiment Video
Updated: Aug 14, 2026

14:22
Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
Published on: July 16, 2011
Liver-specific gene expression in cultured human hematopoietic stem cells
Henning C Fiegel1, Michael V Lioznov, Lourdes Cortes-Dericks
1Bone Marrow Transplantation Center, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. fiegel@uke.uni-hamburg.de
Stem Cells (Dayton, Ohio)
|January 17, 2003
Summary
Adult human bone marrow stem cells expressing CD34 can transform into liver cells in a laboratory setting. This research highlights the potential of CD34(+) cells for hepatocytic differentiation, offering new avenues for regenerative medicine.
Area of Science:
- Stem cell biology
- Hepatology
- Regenerative medicine
Background:
- Hematopoietic and hepatic stem cells share common surface markers.
- Emerging evidence suggests hepatocytes may originate from bone marrow.
Purpose of the Study:
- To investigate the potential of CD34(+) bone marrow cells to differentiate into hepatocytic cells in vitro.
- To determine if CD34(+) cells express liver-specific markers after differentiation.
Main Methods:
- Human bone marrow cells were separated into CD34(+) and CD34(-) populations using magnetic cell sorting.
- Cells were cultured on a collagen matrix with hepatocyte growth factor.
- Flow cytometry was used for cell count and size analysis, and Ki-67 staining assessed proliferation.
- Reverse transcription polymerase chain reaction (RT-PCR) detected liver-specific gene expression (CK-19 and albumin).
Main Results:
- CD34(+) cells exhibited increased cell numbers and proliferation (Ki-67 staining) during culture.
- After 28 days, CD34(+) cells expressed albumin and CK-19 RNA.
- CD34(-) cells did not demonstrate significant liver-specific gene expression.
Conclusions:
- CD34(+) adult human bone marrow stem cells possess the capacity for in vitro differentiation into hepatocytic cells.
- This finding supports the potential use of CD34(+) cells in therapeutic strategies for liver diseases.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

